A Rising Cost Forecast Is Not a Purchasing Plan
When a health-plan forecast rises, the first instinct is often to ask what will be added to the employee contribution or which benefit will be reduced. Those are budget questions. They are not yet purchasing questions.
For a self-funded employer, a forecast should trigger a disciplined look at the parts of the plan that leadership can actually understand, test, and manage. That takes more than a percentage on a renewal slide.
The source idea: cost pressure has more than one cause
A recent report on employer health costs points to pressure from several directions: complex cancer care, specialty pharmacy, increased use of weight-loss drugs, and administrative costs associated with surprise-billing disputes. It also describes more employers looking for visibility and control by self-funding their plans.
That is an important distinction. Self-funding does not make medical inflation disappear. It gives an employer a closer connection to claims, vendors, contracts, and care decisions. Whether that becomes better control depends on what the employer does with that connection.
Do not turn one number into one diagnosis
A double-digit forecast may be real, but it does not tell a CEO or CFO what changed. A pharmacy increase may reflect specialty drugs, a benefit design change, rebates, unit prices, utilization, or a data-timing issue. A medical increase may be a few large claims, a site-of-care pattern, a network payment issue, or an ordinary run of higher utilization. Sometimes the available reporting cannot answer the question cleanly. That remains unknown until the team gets the right evidence.
That is why a renewal percentage should be treated as a question list, not a verdict. Ask what portion of the projected change is fixed cost, what portion is claims, how much is pharmacy, and which assumptions are estimates rather than settled facts. Then ask what can be influenced before the next plan year without creating needless disruption for employees.
Build a purchasing calendar, not a scramble
For Midwest employers, the useful work usually starts well before the renewal presentation. Put a calendar around the decisions that need lead time: claims and pharmacy review, stop-loss underwriting, contract review, vendor performance questions, benefit-design options, employee communication, and formal approval.
Each item needs an owner and a decision date. The finance leader needs a budget view. The plan fiduciary or committee needs a prudent process and a record of the information considered. The operations or HR lead needs to understand what a change will mean for employees. Outside advisors and vendors can supply analysis, but they cannot supply the employer's internal ownership.
Also separate observation from conclusion. A high-cost claim is an observation. A request for a clinical or payment review may be a reasonable next step. It is not proof that a provider, employee, or vendor did something wrong. Good governance leaves room for a clear explanation before it jumps to a remedy.
Use the forecast to set better questions
Paul H. Flowers Jr. at Superior Insurance Advisors and Paul.Health helps employers turn scattered plan information into a working decision file: what the contract says, what the claims and pharmacy evidence show, what has not been established, and which choices are still open. The goal is not to promise a single savings number. It is to give leadership a more reliable way to buy, oversee, and explain the plan.
A forecast can be uncomfortable. It can also be useful if it arrives early enough to produce better questions instead of a rushed reaction.
Source: Axios, “Employer health cost crunch is worse than projected”, November 16, 2026, accessed November 16, 2026. Additional fiduciary context: U.S. Department of Labor, “Understanding Your Fiduciary Responsibilities Under a Group Health Plan”. This article is original educational commentary, not legal, tax, investment, or fiduciary advice. Plan documents, contracts, and applicable law govern.
Five questions for the next leadership meeting
- Which projected costs are supported by paid-claims or pharmacy evidence, and which are assumptions?
- What changed in medical, pharmacy, stop-loss, and administrative cost separately?
- Which decisions need to be made before renewal to avoid a rushed employee transition?
- Who owns the review, the vendor questions, and the record of the final decision?
- What would leadership need to see before it changes benefits, contracts, or contribution levels?
Does your next health-plan forecast lead to a clear purchasing decision, or only to a larger number?